| Symbol |
Name |
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGRN
|
agrin
|
|
AGRP
|
agouti related neuropeptide
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARG2
|
arginase 2
|
|
ARHGAP1
|
Rho GTPase activating protein 1
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARRB2
|
arrestin, beta 2
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP4B
|
ATPase, H+/K+ exchanging, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTG2
|
BTG family, member 2
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALCR
|
calcitonin receptor
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN10
|
calpain 10
|
|
CAPNS2
|
calpain, small subunit 2
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD209
|
CD209 molecule
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CDA
|
cytidine deaminase
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CLOCK
|
clock circadian regulator
|
|
CMA1
|
chymase 1, mast cell
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNS
|
cystinosin, lysosomal cystine transporter
|
|
CUL4B
|
cullin 4B
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DUSP9
|
dual specificity phosphatase 9
|
|
EDN1
|
endothelin 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EMP1
|
epithelial membrane protein 1
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EXO1
|
exonuclease 1
|
|
EXOSC3
|
exosome component 3
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FKBP5
|
FK506 binding protein 5
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAS6
|
growth arrest-specific 6
|
|
GCG
|
glucagon
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GYG1
|
glycogenin 1
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH2
|
histamine receptor H2
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIPC
|
lipase, hepatic
|
|
LMNA
|
lamin A/C
|
|
LTA
|
lymphotoxin alpha
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MICU1
|
mitochondrial calcium uptake 1
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR134
|
microRNA 134
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR192
|
microRNA 192
|
|
MIR486-1
|
microRNA 486-1
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNS1
|
meiosis-specific nuclear structural 1
|
|
MSLN
|
mesothelin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NEDD1
|
neural precursor cell expressed, developmentally down-regulated 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NRP2
|
neuropilin 2
|
|
OTUD6B
|
OTU domain containing 6B
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PER1
|
period circadian clock 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLG
|
plasminogen
|
|
PLIN2
|
perilipin 2
|
|
PNOC
|
prepronociceptin
|
|
PPL
|
periplakin
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRL
|
prolactin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP9
|
RAN binding protein 9
|
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3
|
|
RDH8
|
retinol dehydrogenase 8 (all-trans)
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RHOA
|
ras homolog family member A
|
|
RLN2
|
relaxin 2
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPS14
|
ribosomal protein S14
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A12
|
S100 calcium binding protein A12
|
|
SCEL
|
sciellin
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SDC3
|
syndecan 3
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
|
|
SERPINA4
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SPRR3
|
small proline-rich protein 3
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STT3B
|
STT3B, subunit of the oligosaccharyltransferase complex (catalytic)
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYVN1
|
synovial apoptosis inhibitor 1, synoviolin
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TH
|
tyrosine hydroxylase
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TTR
|
transthyretin
|
|
TXN
|
thioredoxin
|
|
TXNDC12
|
thioredoxin domain containing 12 (endoplasmic reticulum)
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UBB
|
ubiquitin B
|
|
UBC
|
ubiquitin C
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UBE2S
|
ubiquitin-conjugating enzyme E2S
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
USP15
|
ubiquitin specific peptidase 15
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VPS26A
|
vacuolar protein sorting 26 homolog A (S. pombe)
|
|
VPS26B
|
vacuolar protein sorting 26 homolog B (S. pombe)
|
|
VWF
|
von Willebrand factor
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XAGE1B
|
X antigen family, member 1B
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YBX1
|
Y box binding protein 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZFP36
|
ZFP36 ring finger protein
|
